Michael S. Heyl
Partner
Washington, D.C.
Practice Group
Regulatory
As a Hogan Lovells partner in the firm's accomplished Medical Devices Practice, Mike Heyl helps medical device companies navigate myriad regulatory and business matters. He guides clients through U.S. Food and Drug Administration (FDA) regulations, requirements, and compliance issues. These issues include FDA's Quality System Regulation (QSR); adverse event reporting; recall reporting requirements; FDA inspections and enforcement actions, such as Warning Letters; defense strategies; and corrective and remedial action plans.
He represents large multinational corporations facing FDA and criminal enforcement, and helps small start-ups develop and implement post-market compliance programs. Because he understands FDA's requirements for importing and exporting medical devices, Mike is frequently called on to negotiate the release of detained goods being imported to the U.S.
He has assisted in the defense of criminal investigations by the U.S. Department of Justice, conducted internal investigations of whistleblower complaints, and prepared strategies for resolving such issues.
Mike also works with device companies in conducting regulatory due diligence and negotiating corporate mergers and acquisitions and initial public offerings. He has been involved with numerous transactions ranging from multibillion dollar acquisitions to the negotiation of supply and distribution agreements.
Mike is a frequent speaker on regulatory compliance and enforcement issues in the device industry. He also serves as the device representative on the Hogan Lovells Life Sciences Steering Committee.
Areas of focus
Representative experience
Latest thinking and events
Medical Device Alert
User Fee Reauthorization Bill Includes Legislation Proposed to Improve Medical Device Regulation
Hogan Lovells Publications
FDA Issues Final Guidance on Benefit-Risk Factors to Consider in Medical Device Product Availability, Compliance, and Enforcement Decisions
Medical Device AlertHogan Lovells Publications
FDA Issues New Final Guidance on Medical Device Reporting Requirements
Medical Device AlertHogan Lovells Events
Life Sciences in Sydney: Cocktails and Conversation
28 September 2016
Hogan Lovells Publications
DuPont's Upgraded Manufacturing Process Regarding Their Tyvek® Material and Impact on Medical Device Manufacturers
Medical Device AlertHogan Lovells Publications
Final FDA Guidance Clarifies Distinction Between Medical Device Recalls and Enhancements
Medical Device AlertView More
